How Injecting Under Medical Supervision Could Help Fight The Opioid Epidemic
As officials struggle to fight the opioid epidemic that is plaguing the country, some big cities are considering creating "safe injection" sites. Addicts would be able to use their drugs under the watch of medical professionals, and they would be provided clean needles. While no city has submitted a formal plan, the idea is already stirring up controversy.
Dina Fine Maron, Health & Medicine Editor at Scientific American, explains the science behind safe injection sites. Allowing addicts to use drugs under supervision and with clean needles helps to reduce diseases associated with intravenous drug use such as HIV.
While no city in the United States has a "safe injection" site, Fine Maron says existing sites in Europe and Canada have proven to be a success. Data shows that opening these sites helps reduce opioid-related deaths and problems.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
